Laser and Medical Treatment of Diabetic Macular Edema
NCT00027287 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2008-03-04
Summary
This study will compare the side effects of two laser treatments for diabetic macular edema, a common condition in patients with diabetes. In macular edema, blood vessels in the retina-a thin layer of tissue that lines the back of the eye-become leaky and the retina swells. The macula-the center part of the retina that is responsible for fine vision-may also swell and cause vision loss. Traditional laser treatment (argon blue or green or yellow) for macular swelling, or edema, causes scarring that can expand and possibly lead to more loss of vision. Studies with a different type of laser (diode) have shown no adverse effects to the retina, but long-term effects of this treatment are not known. The results of this study on side effects of the treatments will be used to design a larger study of effectiveness. This study will also examine whether vitamin E can reduce the damage caused by laser treatment. Patients with diabetic eye disease who take vitamin E have increased blood flow through the vessels of the retina, as well as improved kidney function. Patients with elevated cholesterol levels will be invited to participate in a cholesterol reduction part of the study to compare normal-pace cholesterol reduction with accelerated reduction.
Patients 18 years of age and older with type 1 or type 2 diabetes and macular edema may be eligible for this study. Candidates will be screened with the following tests and procedures:
* Medical history - to review past medical conditions and treatments.
* Physical examination - to measure vital signs (pulse, blood pressure, temperature, breathing rate) and examine the head and neck, heart, lungs, abdomen, arms and legs.
* Eye examination - to assess visual acuity (eye chart test) and examine pupils, lens, retina, and eye movements. The pupils will be dilated with drops for this examination.
* Blood tests - to measure cholesterol and vitamin E blood levels, blood clotting time, hemoglobin A1C (a measure of diabetes control), and to evaluate liver and kidney function.
* Photography - to help evaluate the status of the retina and changes that may occur in the future. Special photographs of the inside of the eye are taken using a camera that flashes a bright light into the eye. From 2 to 20 pictures may be taken, depending on the eye condition.
* Fluorescein angiography - to evaluate the eye's blood vessels. A yellow dye is injected into an arm vein and travels to the blood vessels in the eyes. Pictures of the retina are taken using a camera that flashes a blue light into the eye. The pictures show if any dye has leaked from the vessels into the retina, indicating possible blood vessel abnormality.
Participants will be randomly assigned to receive one of the two laser treatments. They will also be randomly assigned to take 1600 IU of vitamin E or placebo (an inactive, look-alike pill) daily. For the laser treatment, eye drops are put in the eye to numb the surface and a contact lens is placed on the eye during the laser beam application. Several visits may be required for additional laser treatments. The maximum number of treatments depends on how well the treatment is working.
On their first visit, patients will be given vitamin C. After taking the vitamin for 1 month, they will return to the clinic for the first laser treatment. They will followed 1, 3, 6, 9, and 12 months after the first treatment, and then every 6 months until either 1) the patient returns for a 3-year visit; 2) the last enrolled patient returns for the 1-year visit, or the patient requests to leave the study. During these visits, several of the exams described above will be repeated to evaluate the response to treatment and check for side effects of the vitamin E.
Conditions
- Diabetes Mellitus
- Macular Edema
Interventions
- DRUG
-
Vitamin E
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Study Design
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-11-30
- Completion
- 2002-12-31
Countries
- United States
Study Locations
More Related Trials
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema
NCT00231023 ·Status: COMPLETED ·Phase: PHASE2
-
Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema
NCT05582577 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema
NCT05759884 ·Status: UNKNOWN ·Phase: NA
-
Photobiomodulation for the Treatment of Diabetic Macular Edema
NCT02457975 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema
NCT00367133 ·Status: COMPLETED ·Phase: PHASE3
-
Micropulse Laser in Treatment of Initial and Refractory Cases of Center-Involved Diabetic Macular Edema
NCT07295704 ·Status: RECRUITING
-
Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
NCT06205979 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema
NCT04359771 ·Status: COMPLETED ·Phase: PHASE4
-
Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema
NCT02441907 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema
NCT01168258 ·Status: TERMINATED
-
A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema
NCT00148265 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Vitrectomy for Diabetic Macular Edema
NCT00709319 ·Status: COMPLETED
-
A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema
NCT00369486 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema
NCT00464685 ·Status: COMPLETED ·Phase: PHASE2
-
Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.
NCT03458923 ·Status: UNKNOWN ·Phase: PHASE4
-
A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema
NCT02876393 ·Status: COMPLETED
-
Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
NCT00320814 ·Status: COMPLETED ·Phase: PHASE1
-
Imaging Parameters and DME Treatment Response
NCT02637245 ·Status: COMPLETED
-
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
NCT00444600 ·Status: COMPLETED ·Phase: PHASE3
-
Glycemic Control and Diabetic Macular Edema
NCT01358396 ·Status: COMPLETED
-
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes
NCT07270133 ·Status: NOT_YET_RECRUITING
-
Micropulse for Suppression of Diabetic Macular Edema
NCT03519581 ·Status: COMPLETED ·Phase: NA
-
Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED).
NCT02650050 ·Status: TERMINATED ·Phase: NA
-
A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)
NCT00457470 ·Status: WITHDRAWN ·Phase: PHASE2